FTD: Clinical Trials

3 trials for FTD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 recruiting. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 2, Recruiting 1
Phase 23Terminated 2, Recruiting 1

Follow FTD: new trials by email Literature Review of FTD trials Research Report on FTD

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101 - Frontotemporal Dementia, FTD
Phase 1 / Phase 2RecruitingAviadoBio Ltd182023-08-302026-08-13
A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes
PBFT02 - Frontotemporal Dementia, FTD
Phase 1 / Phase 2TerminatedPassage Bio, Inc.302021-09-142026-10-29
Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
WVE-004, Placebo - ALS, FTD
Phase 1 / Phase 2TerminatedWave Life Sciences USA, Inc.352021-06-282023-10-23

Narrower conditions

Frontotemporal Dementia (2)  ·  Aphasia, Primary Progressive (1)  ·  Dementia (1)  ·  Frontotemporal Dementia With Motor Neuron Disease (1)  ·  Pick Disease of the Brain (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Frontotemporal Lobar Degeneration (2)  ·  Mental Disorders (2)  ·  Metabolic Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurocognitive Disorders (2)  ·  Neurodegenerative Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Proteostasis Deficiencies (2)  ·  TDP-43 Proteinopathies (2)  ·  Aphasia (1)  ·  Communication Disorders (1)  ·  Dementia (1)  ·  Language Disorders (1)

Sponsors

AviadoBio Ltd (1)  ·  Passage Bio, Inc. (1)  ·  Wave Life Sciences USA, Inc. (1)

Countries

Canada (3)  ·  Australia (2)  ·  Belgium (2)  ·  Netherlands (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Brazil (1)  ·  Ireland (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Portugal (1)  ·  Spain (1)

NIH funding

2023 (1)